Chronic effects of clofibric acid in zebrafish (Danio rerio): A multigenerational study
-
Add time:08/31/2019 Source:sciencedirect.com
Clofibric acid (CA) is an active metabolite of the blood lipid lowering agent clofibrate, a pharmaceutical designed to work as agonist of peroxisome proliferator-activated receptor alpha (PPARa). It is the most commonly reported fibrate in aquatic environments with low degradation rate and potential environmental persistence. Previous fish exposures showed that CA may impact spermatogenesis, growth and the expression of fat binding protein genes. However, there are limited data on the effects of chronic multigenerational CA exposures.Here, we assessed chronic multigenerational effects of CA exposure using zebrafish (Danio rerio) as a teleost model. Zebrafish were exposed through the diet to CA (1 and 10 mg/g) during their whole lifetime. Growth, reproduction-related parameters and embryonic development were assessed in the exposed fish (F1 generation) and their offspring (F2 generation), together with muscle triglyceride content and gonad histology. In order to study the potential underlying mechanisms, the transcription levels of genes coding for enzymes involved in lipid metabolism pathways were determined.The results show that chronic life-cycle exposure to CA induced a significant reduction in growth of F1 generation and lowered triglyceride muscle content (10 mg/g group). Also, an impact in male gonad development was observed together with a decrease in the fecundity (10 mg/g group) and higher frequency of embryo abnormalities in the offspring of fish exposed to the lowest CA dose.The profile of the target genes was sex- and tissue-dependent. In F1 an up-regulation of male hepatic pparaa, pparb and acox transcript levels was observed, suggesting an activation of the fatty acid metabolism (provided that transcript level change indicates also a protein level change). Interestingly, the F2 generation, raised with control diet, displayed a response pattern different from that observed in F1, showing an increase in weight in the descendants of CA exposed fish, in comparison with control animals, which points to a multigenerational effect.
We also recommend Trading Suppliers and Manufacturers of clofibric acid-coenzyme A (cas 104732-21-0). Pls Click Website Link as below: cas 104732-21-0 suppliers
Prev:FT-IR spectroscopic investigations on sol–gel-derived coatings from acid-modified titanium alkoxides
Next:Full PaperClofibric Acid Increases the Formation of Oleic Acid in Endoplasmic Reticulum of the Liver of Rats) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Molecular and Cellular PharmacologyEffects of the peroxisome proliferator clofibric acid on superoxide dismutase expression in the human HepG2 hepatoma cell line09/08/2019
- Regular paperBezafibrate and clofibric acid are novel inhibitors of phosphatidylcholine synthesis via the methylation of phosphatidylethanolamine09/07/2019
- Effects of the lipid regulating drug clofibric acid on PPARα-regulated gene transcript levels in common carp (Cyprinus carpio) at pharmacological and environmental exposure levels09/06/2019
- Short communicationEffects of gemfibrozil and clofibric acid on the uptake of taurocholate by isolated rat hepatocytes☆09/05/2019
- Full PaperStearoyl-CoA Desaturase Activity Is Elevated by the Suppression of Its Degradation by Clofibric Acid in the Liver of Rats09/04/2019
- Separation and measurement of clofibroyl coenzyme a and clofibric acid in rat liver after clofibrate administration by reversed-phase high-performance liquid chromatography with photodiode array detection09/03/2019
- Metabolism of clofibric acid in zebrafish embryos (Danio rerio) as determined by liquid chromatography–high resolution–mass spectrometry09/02/2019
- Full PaperClofibric Acid Increases the Formation of Oleic Acid in Endoplasmic Reticulum of the Liver of Rats09/01/2019


